FAMOTIDINE PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
When do Famotidine Preservative Free patents expire, and when can generic versions of Famotidine Preservative Free launch?
Famotidine Preservative Free is a drug marketed by Apothecon, Epic Pharma Llc, Fresenius Kabi Usa, Hikma, Hospira, Mylan Labs Ltd, Sagent, Abbvie, and Baxter Hlthcare. and is included in twelve NDAs.
The generic ingredient in FAMOTIDINE PRESERVATIVE FREE is famotidine. There are eighteen drug master file entries for this compound. One hundred and thirty-seven suppliers are listed for this compound. Additional details are available on the famotidine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Famotidine Preservative Free
A generic version of FAMOTIDINE PRESERVATIVE FREE was approved as famotidine by FRESENIUS KABI USA on April 16th, 2001.
Summary for FAMOTIDINE PRESERVATIVE FREE
US Patents: | 0 |
Applicants: | 9 |
NDAs: | 12 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 10 |
Patent Applications: | 7,161 |
Formulation / Manufacturing: | see details |
DailyMed Link: | FAMOTIDINE PRESERVATIVE FREE at DailyMed |
Pharmacology for FAMOTIDINE PRESERVATIVE FREE
Drug Class | Histamine-2 Receptor Antagonist |
Mechanism of Action | Histamine H2 Receptor Antagonists |